EFDID: 387991EFD: View Filing

Issuer: PROVECTUS BIOPHARMACEUTICALS, INC. (0000315545) - D

Accession: 0000315545-21-000001 (XMLRaw Data) (EDGAREDGAR Files) (Form DForm D)

EDGAR: Issuer Information
  • CIK:
    0000315545
  • Entity Name:
    PROVECTUS BIOPHARMACEUTICALS, INC.
  • Entity Type:
    Corporation
  • Jurisdiction:
    DELAWARE
  • Year of Inc:
    Over 5 years ago
  • Address:
    10025 INVESTMENT DRIVE
    SUITE 250
    KNOXVILLE, TN 37932
  • Persons:
    Related Persons 7
    Webster Bailey
    Director
    Bruce Horowitz
    Executive Officer, Director
    John Lacey, III
    Director
    Ed Pershing
    Director
    Dominic Rodrigues
    Director
    Heather Raines
    Executive Officer
    Eric Wachter
    Executive Officer
EDGAR: Offering Information
  • Accession Date:
    08/30/2021
  • First Sale Date:
    08/16/2021
  • Offering Amount:
    $5,000,000
  • Amount Sold:
    $200,000
  • Amount Remaining:
    $4,800,000
  • Exemptions:
    Rule 506
  • Security Type(s):
    Debt
EFD: Current State Notices
View Notices

Notices found in EFD

Filed:None
Inactive:TN
EDGAR: Sales Compensation Recipient Information

There were no Sales Compensation Recipient Information associated with this Accession Number.

EDGAR: Signatures
IssuerSignatureSigner NameTitleSignatureDate
PROVECTUS BIOPHARMACEUTICALS, INC./s/ Heather RainesHeather RainesChief Financial Officer2021-08-30